Heart Test Laboratories Inc. Warrant

Profitability for 1 year: +81.82%
Dividend yield: 0%

Heart Test Laboratories Inc. Warrant

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
-0.0107 -1333.21 -100% -0.0043 +147.69%
P/S 21.61 32.06 -32.59%
P/BV 0.46 -179.78 -100.25%
P/FCF -0.0126 -1263.3 -100%
Ev/Ebitda -0.24 -1765.19 -99.99%
Ev/S 442.45 8.13 5339.11%
Ev/FCF -0.26 -1286.26 -99.98%
E/P -93.25 -0.0025 3805634.11%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-187053.33 5.63 -3320612.62% -111581.24 +67.64%
ROE -4272.16 171.81 -2586.61%
ROA -207.56 -43.74 374.54%
ROIC 0 0 0%
ROS -192013.13 5.16 -3721284.69%
ROCE -4028.24 -15.81 25387.12%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.37 0.0198 -1954.23% -0.5 -25.92%
Nеt Debt/Ebitda -0.23 -0.27 -14.04%
Debt/Ratio 0.71 0.0738 857.66%
Debt/Equity 19.58 -0.78 -2624.31%
Debt/Net Income -0.34 -0.0578 489.24%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0 0% 0 0%
Number of years of dividend growth 0 0 0%
DSI 0 0 0%
Average dividend growth 0 0 0%
Average percentage for 5 years 0 0 0%
Average percentage for payments 0 0 0%
Difference from average difference in sector 0

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
-83.01 294.53 -128.18%
Growth impulse Ebitda in 5 years 220.6 492.37 -55.2%
Growth impulse Net Income in 5 years 239.58 146.17 63.91%
Growth impulse FCF in 5 years 203.43 -77.7 -361.81%
Growth impulse EPS in 5 years -88.01 -177.03 -50.29%
IP Score
3.56/10

Similar companies

Turnstone Biologics Corp. Common Stock

Apollomics, Inc.

SenesTech, Inc.

ZeroFox Holdings, Inc.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription